drugset / Trial / NCT02596997

Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

NCT02596997

Expanded access No longer available Jazz Pharmaceuticals

Summary

Provide patients with serious AdV infection or disease access to treatment with BCV.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Brincidofovir Other / unclassified 100 mg